Imaradenant Uses, Dosage, Side Effects and more
Imaradenant is under investigation in clinical trial NCT03381274 (Oleclumab (MEDI9447) Egfrm NSCLC Novel Combination Study).
| Trade Name | Imaradenant |
| Generic | Imaradenant |
| Imaradenant Other Names | Imaradenant |
| Type | |
| Formula | C15H11ClFN5 |
| Weight | Average: 315.74 Monoisotopic: 315.0687012 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
